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Active Bacterial Core Surveillance (ABCs) Report
Emerging Infections Program Network
Neisseria meningitidis, 1999
ABCs Areas
California (3 county San Francisco Bay area); Connecticut;
Georgia; Maryland; Minnesota; New York (15 county
Rochester/Albany area); Oregon; Tennessee (5 urban
counties)
ABCs Population
The surveillance areas represent 31,711,122 persons.
Source: U.S. Bureau of the Census, 1999
ABCs Case Definition
Invasive meningococcal disease:  isolation of Neisseria
meningitidis from normally sterile site in a resident of a
surveillance area in 1999. 
ABCs Methodology
Project personnel communicated at least monthly with
contacts in all microbiology laboratories serving acute care
hospitals in their area to identify cases.  Standardized case
report forms that include information on demographic
characteristics, clinical syndrome, and outcome of illness
were completed for each identified case.  Molecular
subtyping was done on meningococcal isolates at CDC.
Regular laboratory audits assess  completeness of active
surveillance and detect additional cases.
  
All rates of  invasive meningococcal disease were calculated
using U.S. Bureau of the Census postcensal population
estimates for 1999.  
For  national projections of cases, race- and age-specific rates
of disease were applied from the aggregate surveillance area
to the age and racial distribution of the 1999 U.S. population.
Cases with unknown race were distributed by area based on
reported race distribution for known cases within the eight
age categories.
Reported ABCs Profiles
Race No. (Rate*)
White 247 (1.0)
Black 85 (1.6)
Other 15 (0.9)
Total 347 (1.1)
Unknown race (n=40 ) distributed among knowns
*Cases per 100,000 population for ABCs areas.
Cases Deaths
Syndrome No. (%*) No. (Rate†)
Meningitis 162 (46.7) 17 (10.5)
Bacteremia w/o focus 139 (40.1) 18 (12.9)
*Percent of cases.  †Deaths per 100 cases with known outcome
Age
(years)
Serogroups 
B C Y Other
 No. (Rate*)  No. (Rate)  No. (Rate)  No. (Rate)
<1 26 (6.0) 8 (1.8) 16 (3.7) 4 (0.9)
1 4 (0.9) 2 (0.5) 2 (0.5) 1 (0.2)
2-4 15 (1.2) 12 (0.9) 3 (0.2) 4 (0.3)
5-17 15 (0.3) 28 (0.5) 18 (0.3) 3 (0.1)
18-34 23 (0.3) 26 (0.3) 17 (0.2) 7 (0.1)
35-49 11 (0.1) 6 (0.1) 14 (0.2) 7 (0.1)
50-64  6 (0.1) 2 (0.04) 11 (0.2) 6 (0.1)
>65 8 (0.2) 7 (0.2) 25 (0.7) 10 (0.3)
Total 108 (0.3) 91 (0.3) 106 (0.3) 42 (0.1)
*
 Cases per 100,000 population for ABCs areas
Serogroup B Isolates
Serosubtypes No. (%)
Serotypes:
Serosubtype No. (%)
P1.7,16 12 24 15:P1.7,16 11 22
P1.22a,14 9 18 NT:P1.22a,14 6 12
P1.4 4 8 2A:P1.5,2 3 6
P1.5,2 4 8 4,7:P1.4 3 6
P1.6 3 6 14:NT 2 4
P1.7,1 3 6 4,7:P1.7,1 2 4
*OR isolates not included due to continuing increase of P1.7,16
National Projection for Invasive Disease:
Cases:     2,957 (1.1/100,000)   
Deaths:     316  (0.1/100,000)
Healthy People 2010 Update:
Objective: Reduce the incidence of invasive meningococcal
disease to 0.9 per 100,000 population.
2010 Objective 1999 Rate*
0.9/100,000 1.1
*Cases per 100,000 U.S. population.
Source: ABCs/NETSS
For more information, visit our web site at:
http://www.cdc.gov/abcs
